Francis Burrows
13Patents
11h-index
14Co-inventors
69Inventor score
Filing activity: Mar 2, 1994 → Sep 28, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6051230A | Compositions for targeting the vasculature of solid tumors | Emerging Cross-Sectional Technologies | 258 | Expired |
| US5855866A | Methods for treating the vasculature of solid tumors | Chemistry; Metallurgy | 256 | Expired |
| US5776427A | Methods for targeting the vasculature of solid tumors | Chemistry; Metallurgy | 215 | Expired |
| US5660827A | Antibodies that bind to endoglin | Chemistry; Metallurgy | 130 | Expired |
| US6261535A | Diagnostic methods for targeting the vasculature of solid tumors | Emerging Cross-Sectional Technologies | 107 | Expired |
| US5863538A | Compositions for targeting the vasculature of solid tumors | Emerging Cross-Sectional Technologies | 107 | Expired |
| US5965132A | Methods and compositions for targeting the vasculature of solid tumors | Emerging Cross-Sectional Technologies | 85 | Expired |
| US7125541B2 | Combined methods for tumor vasculature targeting and tumor treatment with radiotherapy | Emerging Cross-Sectional Technologies | 69 | Expired |
| US6004554A | Methods for targeting the vasculature of solid tumors | Chemistry; Metallurgy | 61 | Expired |
| US7112317B2 | Combined methods and compositions for tumor vasculature targeting and tumor treatment | Emerging Cross-Sectional Technologies | 41 | Expired |
| US7465718B2 | Ansamycins having improved pharmacological and biological properties | Chemistry; Metallurgy | 14 | Expired |
| US11944627B2 | Methods for treating hematological malignancies and Ewing's sarcoma | Human Necessities | 0 | Active |
| US11672774B2 | Methods of treating squamous cell carcinomas with farnesyltransferase inhibitors | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.